Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
gene sequencing
Asia
Gilead's remdesivir, Takeda, Glenmark and more—FiercePharmaAsia
Coronavirus leads to remdesivir patent case. Takda's looking to sell a Shire biologics plant. Glenmark spinoff Ichnos recruits Novartis exec.
Angus Liu
Feb 7, 2020 9:00am
Coronavirus drugs, Sanofi, Novartis and more—FiercePharmaAsia
Jan 31, 2020 9:15am
New Lynparza data back Merck and AZ’s prostate cancer bid
Aug 7, 2019 10:57am
Daiichi, China's first biosim and more—FiercePharmaAsia
Mar 1, 2019 10:20am
Dogs face more risk for hereditary diseases than originally assumed
Aug 23, 2016 7:03pm
Imagene, LifeNome target personalized genomic tests
Jun 1, 2016 1:29am
